Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Marwitz, G. Zissel, P. Zabel, C. Kugler, E. Vollmer, T. Goldmann (Borstel, Freiburg, Großhansdorf, Germany). Ex vivo trans-differentiation of primary human alveolar epithelial cells type II by TGFb. Eur Respir J 2014; 44: Suppl. 58, 3509

Member's Comments

No comment yet.

Related content which might interest you: Establishment of alveolar epithelial progenitor cells from the lung with ABCA3 mutations Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Change of A549 cells characteristics upon stimulation with BALF of patients with interstitial lung diseases Source: International Congress 2014 – ILDs 4 Year: 2014 The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway Source: International Congress 2014 – ILDs 1 Year: 2014 HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Alveolar type II cells transplantation in pulmonary fibrosis: Effect on the lung macrophage activation Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Effect of pirfenidone on TGF-beta-induced pro-fibrotic effects in primary human lung cells derived from patients with idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling? Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 The role of CCR2+CD4+T cells in lung fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Identification of novel proteins involved in beta-catenin dependent alveolar epithelial trans-differentiation Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Mesenchymal stem cells isolated from fibrotic human lung tissue inhibit collagen expression by lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Nintedanib prevents IL-1beta-stimulated proliferation of primary human lung fibroblasts from patients with idiopathic pulmonary fibrosis or from control donors Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Fibroblast heterogeneity in the diseased lung Source: International Congress 2014 – ILDs 3 Year: 2014 Type V collagen induced pulmonary fibrosis in C57Bl/6mice Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Dasatinib suppresses TGFbeta-induced epithelial mesenchymal transition and inhibits pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014 ABCA3 mutations disturb lipid homeostasis in alveolar epithelial cells Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Bone marrow stromal cell conditioned media reduces endoplasmic reticulum stress in alveolar epithelial cells in vitro Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine Year: 2014